Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaJay P. Patel, Ross L. Levine, Selina M. Luger et al.|New England Journal of Medicine|2012Cited by 1.9k
Anthracycline Dose Intensification in Acute Myeloid LeukemiaHugo F. Fernández, Martin S. Tallman, Zhuoxin Sun et al.|New England Journal of Medicine|2009Cited by 907
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K. Fielding, Anthony H. Goldstone, Susan Richards et al.|Blood|2006Cited by 843
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)Anthony H. Goldstone, Jacob M. Rowe, Susan Richards et al.|Blood|2007Cited by 782
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V. Moorman, Gordon W. Dewald, Christine J. Harrison et al.|Blood|2006Cited by 746